Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts’ response to fibrotic growth factors

Systemic Sclerosis (SSc) hallmark is skin fibrosis, but up to 80% of the patients have fibrotic involvement in the pulmonary system. Antifibrotic drugs which have failed in a general SSc population have now been approved in patients with SSc-associated interstitial lung disease (ILD). This indicates...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Sofie Falkenløve, Sand, Jannie Marie Bülow, Juhl, Pernille, Karsdal, Morten, Thudium, Christian S., Siebuhr, Anne Sofie, Bay-Jensen, Anne-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256773/
https://www.ncbi.nlm.nih.gov/pubmed/37296166
http://dx.doi.org/10.1038/s41598-023-36416-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256773/
https://www.ncbi.nlm.nih.gov/pubmed/37296166
http://dx.doi.org/10.1038/s41598-023-36416-6

Ejemplares similares